BackIM Cannabis Overview

IM Cannabis Current Cash

IM Cannabis's current cash is $1.2M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$1.15M
↓ 17.12% YoYΔ $-237811.00 vs prior year quarter

Peer average

Loading

IM Cannabis Current Cash History

Loading

IM Cannabis vs. peers: Current Cash Comparison

Loading

IM Cannabis Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

IM Cannabis (IMCC) FAQ

As of the most recent data (March 2026), IMCC shows a current cash of $1.2M. That compares with $1.4M in the prior-year period — down 17.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IMCC's current cash is now $1.2M (was $1.4M) — a 17.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether IM Cannabis is outperforming or lagging.

Tracking IMCC's current cash over time shows whether IM Cannabis is scaling, shrinking, or reshaping that part of the business. The current reading is $1.2M That compares with $1.4M in the prior-year period — down 17.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has IM Cannabis's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $1.2M) with ownership activity and broader fundamentals.

IM Cannabis's current cash is $1.2M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.